Inflammatory markers in AD and MCI patients with different biomarker profiles von Schuitemaker, Alie, Dik, Miranda G, Veerhuis, Robert, Scheltens, Philip, Schoonenboom, Niki S.M, Hack, C. Erik, Blankenstein, Marinus A, Jonker, Cees

Volltext

CSF biomarker levels in early and late onset Alzheimer's disease von Bouwman, Femke H, Schoonenboom, Niki S.M, Verwey, Nicolaas A, van Elk, Evert J, Kok, Astrid, Blankenstein, Marinus A, Scheltens, Philip, van der Flier, Wiesje M

Volltext

Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes von Ouwens, D. Margriet, van Duinkerken, Eelco, Schoonenboom, S. Niki M., Herzfeld de Wiza, Daniella, Klein, Martin, van Golen, Larissa, Pouwels, Petra J. W., Barkhof, Frederik, Moll, Annette C., Snoek, Frank J., Teunissen, Charlotte E., Scheltens, Philip, Diamant, Michaela

Volltext

Functional Brain Connectivity and Neurocognitive Functioning in Patients With Long-Standing Type 1 Diabetes With and Without Microvascular Complications: A Magnetoencephalography S... von VAN DUINKERKEN, Eelco, KLEIN, Martin, SCHOONENBOOM, Niki S. M, HOOGMA, Roel P. L. M, MOLL, Annette C, SNOEK, Frank J, STAM, Cornelis J, DIAMANT, Michaela

Volltext

Effects of processing and storage conditions on amyloid β (1-42) and tau concentrations in cerebrospinal fluid : Implications for use in clinical practice von SCHOONENBOOM, Niki S. M, MULDER, Cees, VANDERSTICHELE, Hugo, VAN ELK, Evert-Jan, KOK, Astrid, VAN KAMP, Gerard J, SCHELTENS, Philip, BLANKENSTEIN, Marinus A

Volltext

CSF Neurofilaments in Frontotemporal Dementia Compared with Early Onset Alzheimer’s Disease and Controls von Pijnenburg, Yolande A.L., Janssen, John C., Schoonenboom, Niki S.M., Petzold, Axel, Mulder, Cees, Stigbrand, Torgny, Norgren, Niklas, Heijst, Hans, Hack, C. Erik, Scheltens, Philip, Teunissen, Charlotte E.

Volltext

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease von Babapour Mofrad, Rosha, Schoonenboom, Niki S.M., Tijms, Betty M., Scheltens, Philip, Visser, Pieter Jelle, van der Flier, Wiesje M., Teunissen, Charlotte E.

Volltext

Amyloid β 38, 40, and 42 species in cerebrospinal fluid: More of the same? von Schoonenboom, Niki S., Mulder, Cees, Van Kamp, Gerard J., Mehta, Sangita P., Scheltens, Philip, Blankenstein, Marinus A., Mehta, Pankaj D.

Volltext

The transmethylation cycle in the brain of Alzheimer patients von Mulder, Cees, Schoonenboom, Niki S.M., Jansen, Erwin E.W., Verhoeven, Nanda M., van Kamp, Gerard J., Jakobs, Cornelis, Scheltens, Philip

Volltext

Cerebrospinal fluid tau levels in frontotemporal dementia von Verbeek, Marcel M., Pijnenburg, Yolande A., Schoonenboom, Niki S., Kremer, Berry P. H., Scheltens, Philip

Volltext

Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders von Bouwman, Femke H, van der Flier, Wiesje M, Schoonenboom, Niki S M, van Elk, Evert J, Kok, Astrid, Scheltens, Philip, Blankenstein, Marinus A

Volltext

Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project von Kunneman, Marleen, Pel-Littel, Ruth, Bouwman, Femke H, Gillissen, Freek, Schoonenboom, Niki S.M, Claus, Jules J, van der Flier, Wiesje M, Smets, Ellen M.A

Volltext

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease von Schoonenboom, Niki S.M, van der Flier, Wiesje M, Blankenstein, Marinus A, Bouwman, Femke H, Van Kamp, Gerard J, Barkhof, Frederik, Scheltens, Philip

Volltext

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design von de Wilde, Arno, van Maurik, Ingrid S, Kunneman, Marleen, Bouwman, Femke, Zwan, Marissa, Willemse, Eline A.J, Biessels, Geert Jan, Minkman, Mirella, Pel, Ruth, Schoonenboom, Niki S.M, Smets, Ellen M.A, Wattjes, Mike P, Barkhof, Frederik, Stephens, Andrew, van Lier, Erik J, Batrla-Utermann, Richard, Scheltens, Philip, Teunissen, Charlotte E, van Berckel, Bart N.M, van der Flier, Wiesje M

Volltext

Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid von Schoonenboom, Niki S M, Mulder, Cees, Vanderstichele, Hugo, Pijnenburg, Yolande A L, Van Kamp, Gerard J, Scheltens, Philip, Mehta, Pankaj D, Blankenstein, Marinus A

Volltext

Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project von Kunneman, Marleen, Smets, Ellen M.A., Bouwman, Femke H., Schoonenboom, Niki S.M., Zwan, Marissa D., Pel-Littel, Ruth, van der Flier, Wiesje M.

Volltext

A novel cognitive-functional composite measure to detect changes in early Alzheimer's disease: Test–retest reliability and feasibility von Jutten, Roos J., Harrison, John, Lee Meeuw Kjoe, Philippe R., Opmeer, Esther M., Schoonenboom, Niki S.M., de Jong, Frank Jan, Ritchie, Craig W., Scheltens, Philip, Sikkes, Sietske A.M.

Volltext

What patients want to know, and what we actually tell them: The ABIDE project von Fruijtier, Agnetha D, Visser, Leonie NC, Bouwman, Femke, Lutz, Rogier, Schoonenboom, Niki SM, Kalisvaart, Kees, Hempenius, Liesbeth, Roks, Gerwin, Boelaarts, Leo, Claus, Jules J, Kleijer, Mariska, Beer, Marlijn, van Der Flier, Wiesje, Smets, Ellen M

Volltext

What patients want to know, and what we actually tell them: The ABIDE project: Implementation of person‐centered care von Fruijtier, Agnetha D, Visser, Leonie NC, Bouwman, Femke, Lutz, Rogier, Schoonenboom, Niki SM, Kalisvaart, Kees, Hempenius, Liesbeth, Roks, Gerwin, Boelaarts, Leo, Claus, Jules J, Kleijer, Mariska, Beer, Marlijn, van Der Flier, Wiesje, Smets, Ellen M

Volltext

Inflammatory markers in AD and MCI patients with different biomarker profiles—interpretation of serum and CSF levels von Schuitemaker, Alie, Dik, Miranda G, Veerhuis, Robert, Scheltens, Philip, Schoonenboom, Niki S.M, Hack, C. Erik, Blankenstein, Marinus A, Jonker, Cees

Volltext